1 Reason I'm Excited About Cameco Stock in 2025

Nuclear energy stocks have rallied and uranium supplier Cameco (CCJ) has climbed over 60% YTD; the company produced roughly 17% of global uranium in 2024 (second to Kazakhstan’s Kazatomprom at 21%), positioning it to benefit from World Nuclear Association forecasts of uranium demand rising about 28% by 2030 and 100% by 2040. U.S. policy tailwinds—illustrated by an $80 billion reactor deal with Westinghouse, which Cameco co-owns with Brookfield—could further boost demand for Cameco’s fuel services, but the shares trade at an elevated multiple of roughly 62x next-year earnings while revenue growth is only expected to be modest in the near term. Given strong secular upside but stretched valuation, investors should weigh exposure carefully and consider diversified nuclear ETFs if seeking less aggressive participation.

Analysis

Cameco (CCJ) has outperformed this year, rising over 60% YTD with a +3.53% move noted in the article, and produced roughly 17% of global uranium in 2024—second only to Kazatomprom at 21% and well ahead of Orano at ~11%—underscoring Cameco’s meaningful market share across mining, refining and fuel services. Industry demand projections from the World Nuclear Association call for uranium demand to rise about 28% by 2030 and 100% by 2040, creating a large secular tailwind that should support higher utilization and pricing over the medium term. Policy and industrial catalysts reinforce that demand case: the White House’s favorable stance on nuclear plus Westinghouse’s $80 billion U.S. reactor deal (a company Cameco co-owns with Brookfield) represent potential sources of incremental fuel sales if project execution proceeds. The counterweight is valuation and near-term fundamentals—shares trade at roughly 62x next-year earnings while revenue is only expected to grow modestly over the next two years—leaving the stock vulnerable to disappointments in execution, slower-than-expected reactor builds, or shifts in commodity prices.

Key Decisions for Investors

• Given the roughly 62x forward multiple and modest near-term revenue growth, investors should avoid initiating large, undisciplined long positions in CCJ and prefer phased entries tied to catalyst execution
• Consider modest exposure via a nuclear energy ETF for diversified participation in the thematic upside while avoiding single-stock valuation risk
• Monitor WNA demand trajectory, progress on the Westinghouse $80bn reactor program (and Cameco/Brookfield execution), and quarterly revenue/earnings cadence as triggers to add, trim, or hedge positions